The global cell-free fetal DNA testing market is experiencing robust growth, with revenue projected to climb from USD 1,566.0 million in 2024 to USD 3,051.5 million by 2035, advancing at a CAGR of 6.1 ...

When you are pregnant, you have so many questions about your baby. Prenatal testing can answer some of those questions. Noninvasive prenatal testing (NIPT) can tell you whether your baby is at risk ...

The global cell-free fetal DNA testing market is experiencing robust growth, with revenue projected to climb from USD 1,566.0 million in 2024 to USD 3,051.5 million by 2035, advancing at a CAGR of 6.1 ...

NEWARK, Del, March 10, 2025 (GLOBE NEWSWIRE) -- The global cell-free fetal DNA testing market is poised for steady growth, projected to reach USD 1,687.8 million by 2025 and expanding at a CAGR of 6.1 ...

Non-invasive prenatal screening techniques can detect chromosomal abnormalities including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). These ...

Physicians must be aware of the technical and ethical considerations for noninvasive prenatal testing in hemolytic disease of the fetus and newborn. Hemolytic disease of the fetus and newborn (HDFN) ...

"We are extremely proud to play a critical role in this clinical trial with the UNITY Fetal Antigen CTA test" said Oguzhan Atay, PhD, CEO of BillionToOne. "The ability to detect fetal antigens as ...

Preeclampsia is a dangerous complication during pregnancy that endangers both the mother and fetus, but clinicians still don't have an effective way of predicting who will develop it. New research has ...

The technology available for prenatal and neonatal genetic screens has advanced at a rapid pace over recent years. In this infographic we’ll explore some of the key concepts in prenatal and neonatal ...

The technology available for prenatal and neonatal genetic screens has advanced at a rapid pace over recent years. In this infographic we’ll explore some of the key concepts in prenatal and neonatal ...